Influence of Disease Acceptance on the Quality of Life of Patients with Ankylosing Spondylitis – Single Centre Study
Open Access
- 1 April 2023
- journal article
- research article
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. ume 17, 1075-1092
Abstract
Introduction: Ankylosing spondylitis (AS) is a chronic, progressive disease, often with multiple complications, with periods of exacerbation and remission. The onset of the disease usually affects people under 30 years of age. The disease impairs physical, psychological, and social functioning, leading to disability. Therefore, patients with AS face the challenge of adapting to life with the condition and deteriorating quality of life (QoL). Objective: This study aimed to assess the impact of disease acceptance on quality of life in patients with AS. Material and Methods: The study was conducted in the Department of Rheumatology and Internal Diseases of the University Hospital in Wrocław among 110 patients (67 men and 43 women) with the diagnosis of AS, aged 20– 89 years (M=48.44 years, SD± 12.55). The study used the Acceptance of Illness Scale (AIS), the WHOQoL-BREF Quality of Life Scale, and a self-constructed questionnaire of clinical and sociodemographic data. Results: Respondents rated the quality of life as good and moderate (M = 3.49 points, SD=± 0.84). The mean AIS score was 27.44 (SD=± 8.67). AIS scores are positively correlated with all QoL domains and perception of quality of life and health (p< 0.001). The strongest correlation was in the physical domain (r=0.71), while the weakest correlation was observed in the social domain (r=0.329). AIS and QoL measures showed significant relationships with selected sociodemographic data (eg, gender, age, education, and occupational activity) and correlated with selected disease data (eg, type of treatment used, duration of disease, or comorbidities). Conclusion: AIS in patients with AS condition correlated positively with their QoL in all domains. Both disease acceptance and quality of life are influenced by specific sociodemographic and disease-related data. Prevention of complications and the type of treatment for AS (primarily biological treatment) can be essential in improving patients’ quality of life.Keywords
This publication has 32 references indexed in Scilit:
- Relationship Between Health-Related Quality of Life and Patient Acceptable Symptom State With Disease Activity and Functional Status in Patients With Ankylosing Spondylitis in ThailandJCR: Journal of Clinical Rheumatology, 2019
- Satisfaction and discontent of Polish patients with biological therapy of rheumatic diseases: results of a multi-center questionnaire studyRheumatology, 2018
- Evaluation of quality of life in patients with axial spondyloarthritis and its association with disease activity, functionality, mobility, and structural damageClinical Rheumatology, 2018
- Socio-demographic determinants of the acceptance of systemic connective tissue diseasesRheumatology, 2018
- Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs: a descriptive analysis of data from interventional trials and the real-world settingArthritis Research & Therapy, 2018
- Quality of life and correlation with clinical and radiographic variables in patients with ankylosing spondylitis: a retrospective case series studyBMC Musculoskeletal Disorders, 2017
- Five Potentially Modifiable Factors Predict Poor Quality of Life in Ankylosing Spondylitis: Results from the Scotland Registry for Ankylosing SpondylitisThe Journal of Rheumatology, 2017
- Erratum to: Fluid signal changes around the knee on MRI are associated with increased volumes of subcutaneous fat: a case-control studyBMC Musculoskeletal Disorders, 2017
- Fatigue and psychosocial variables in autoimmune rheumatic disease and chronic fatigue syndrome: A cross-sectional comparisonJournal of Psychosomatic Research, 2017
- The health-related quality of life of ankylosing spondylitis patients assessed by SF-36: a systematic review and meta-analysisQuality of Life Research, 2016